InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Bowden Christopher, Director. Officer active across 4 companies, notably Ziopharm Oncology INC. Cumulatively, 11 disclosures have been published. The latest transaction was disclosed on 22 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations11 total
040,000 shares0
Common Stock
SEC:0000899243-22-023978:0·
€62,9101,885 shares@ €33.374112.1% of flow
Common stock
SEC:0001439222-21-000059·
€62,9101,885 shares@ €33.37410.0038% mcap12.1% of flow
Common stock
SEC:0001439222-21-000059:0·
€83,5022,502 shares@ €33.374116.1% of flow
Common stock
SEC:0001439222-21-000058·
€83,5022,502 shares@ €33.37410.0050% mcap16.1% of flow
Common stock
SEC:0001439222-21-000058:0·
€233,3317,149 shares@ €32.63830.014% mcap45.0% of flow
Common stock
SEC:0001439222-21-000057:0·
€233,3317,149 shares@ €32.638345.0% of flow
Common stock
SEC:0001439222-21-000057·
€139,1674,268 shares@ €32.607226.8% of flow
Common stock
SEC:0001439222-21-000056·
€139,1674,268 shares@ €32.60720.0083% mcap26.8% of flow
Common stock
SEC:0001439222-21-000056:0·
4,167 shares
Common Stock
SEC:0001209191-21-030737·
04,167 shares0
Common Stock
SEC:0001209191-21-030737:0·
11 of 11 declarations
About Bowden Christopher
Christopher Bowden is the Chief Medical Officer at ZIOPHARM ONCOLOGY INC and AGIOS PHARMACEUTICALS, INC. In this role, he oversees the company's medical and research initiatives. His expertise in the medical field is crucial for innovation and the development of new treatments.
